tizanidine has been researched along with Temporomandibular Disorders in 1 studies
tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilici, IŞ | 1 |
| Emes, Y | 1 |
| Aybar, B | 1 |
| Yalçın, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Effects of Occlusal Splint and Intramuscular Injection in Patients With Myofascial Pain[NCT05228327] | 64 participants (Actual) | Interventional | 2020-08-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for tizanidine and Temporomandibular Disorders
| Article | Year |
|---|---|
Evaluation of the effects of occlusal splint, trigger point injection and arthrocentesis in the treatment of internal derangement patients with myofascial pain disorders.
Topics: Arthrocentesis; Clonidine; Combined Modality Therapy; Humans; Injections; Masticatory Muscles; Melox | 2018 |